BARISUR STUDY: DESCRIPTIVE STUDY OF BARICITINIB SAFETY IN SPANISH PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Rubio Romero, E. [1 ]
Gallego, A. [2 ]
Llanes, M. [3 ]
Delgado Vidal, E. [4 ]
机构：
[1] Seville Hosp Univ Virgen Rocio, Rheumatol, Seville, Spain
[2] Hosp Univ Badajoz, Rheumatol, Badajoz, Spain
[3] Hosp Univ Juan Ramon Jimenez, Rheumatol, Huelva, Spain
[4] Rheumatol, Seville, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Safety; Rheumatoid arthritis; Descriptive studies;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0863
引用
收藏
页码：736 / 736
页数：1
相关论文
共 50 条
  • [1] The safety of baricitinib in patients with rheumatoid arthritis
    Honda, Suguru
    Harigai, Masayoshi
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (05) : 545 - 551
  • [2] Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study
    Guidelli, G. M.
    Viapiana, O.
    Luciano, N.
    De Santis, M.
    Boffini, N.
    Quartuccio, L.
    Birra, D.
    Conticini, E.
    Chimenti, M. S.
    Bazzani, C.
    Bruschi, E.
    Riva, M.
    Canziani, L. M.
    Bianchi, G.
    Pozzi, M. R.
    Limonta, M.
    Gorla, R.
    Perricone, R.
    Frediani, B.
    Moscato, P.
    De Vita, S.
    Dagna, L.
    Rossini, M.
    Selmi, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (04) : 868 - 873
  • [3] Safety and Efficacy of Baricitinib Through 128 Weeks in an Open-label, Longterm Extension Study in Patients with Rheumatoid Arthritis
    Keystone, Edward C.
    Genovese, Mark C.
    Schlichting, Douglas E.
    de la Torre, Inmaculada
    Beattie, Scott D.
    Rooney, Terence P.
    Taylor, Peter C.
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (01) : 14 - 21
  • [4] BARICITINIB IN THE TREATMENT OF PATIENTS WITH MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS IN CHINA: 24-WEEK RESULTS OF POSTMARKETING SAFETY STUDY
    Wu, C. Y.
    Wang, Q.
    Shi, J.
    Zhang, X.
    Du, R.
    Gu, J.
    Liu, Q. H.
    Yu, J.
    Xu, J. W.
    Zhang, Y. J.
    Zhu, H.
    Li, M.
    Zeng, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1418 - 1418
  • [5] Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study
    Li, Z.
    Hu, J.
    Bao, C.
    Li, X.
    Li, X.
    Xu, J.
    Spindler, A. J.
    Zhang, X.
    Xu, J.
    He, D.
    Li, Z.
    Wang, G.
    Yang, Y.
    Wu, H.
    Ji, F.
    Tao, H.
    Zhan, L.
    Bai, F.
    Rooney, T. P.
    Zerbini, C. A. F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (04) : 732 - 741
  • [6] Efficacy and safety of baricitinib in rheumatoid arthritis patients with moderate renal impairment: a multicenter propensity score matching study
    Maeyama, Akira
    Kondo, Masakazu
    Harada, Hiroshi
    Shono, Eisuke
    Nagamine, Ryuji
    Tsuru, Tomomi
    Inoue, Yasushi
    Nakashima, Munetoshi
    Yamasaki, Yutaro
    Niiro, Hiroaki
    Nakashima, Yasuharu
    Yamamoto, Takuaki
    BMC RHEUMATOLOGY, 2024, 8 (01)
  • [7] Chronic comorbidity in patients with early rheumatoid arthritis: A descriptive study
    Kroot, EJJA
    van Gestel, AM
    Swinkels, HL
    Albers, MMC
    van de Putte, LBA
    van Riel, PLCM
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (07) : 1511 - 1517
  • [8] Baricitinib in Patients with Refractory Rheumatoid Arthritis
    Genovese, Mark C.
    Kremer, Joel
    Zamani, Omid
    Ludivico, Charles
    Krogulec, Marek
    Xie, Li
    Beattie, Scott D.
    Koch, Alisa E.
    Cardillo, Tracy E.
    Rooney, Terence P.
    Macias, William L.
    de Bono, Stephanie
    Schlichting, Douglas E.
    Smolen, Josef S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (13) : 1243 - 1252
  • [9] Clinical effectiveness of baricitinib and abatacept in patients with rheumatoid arthritis
    Asai, Shuji
    Takahashi, Nobunori
    Terabe, Kenya
    Yoshioka, Yutaka
    Kojima, Toshihisa
    Kobayakawa, Tomonori
    Sobue, Yasumori
    Watanabe, Tatsuo
    Hirano, Yuji
    Kanayama, Yasuhide
    Kato, Takefumi
    Hanabayashi, Masahiro
    Suzuki, Mochihito
    Imagama, Shiro
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (11)
  • [10] Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study
    Kosuke Ebina
    Toru Hirano
    Yuichi Maeda
    Wataru Yamamoto
    Motomu Hashimoto
    Koichi Murata
    Akira Onishi
    Sadao Jinno
    Ryota Hara
    Yonsu Son
    Hideki Amuro
    Tohru Takeuchi
    Ayaka Yoshikawa
    Masaki Katayama
    Keiichi Yamamoto
    Makoto Hirao
    Yasutaka Okita
    Atsushi Kumanogoh
    Ken Nakata
    Clinical Rheumatology, 2021, 40 : 2673 - 2680
12345